Index S&P 500 P/E 19.88 EPS (ttm) 6.77 Insider Own 0.20% Shs Outstand 112.00M Perf Week -0.75%
Market Cap 14.90B Forward P/E 14.77 EPS next Y 9.11 Insider Trans -6.13% Shs Float 110.08M Perf Month 1.60%
Income 789.00M PEG - EPS next Q 2.27 Inst Own 95.00% Short Float / Ratio 3.71% / 3.82 Perf Quarter 0.18%
Sales 9.60B P/S 1.55 EPS this Y -48.60% Inst Trans -1.34% Short Interest 4.08M Perf Half Y -9.70%
Book/sh 54.02 P/B 2.49 EPS next Y 4.37% ROA 6.00% Target Price 147.60 Perf Year -0.74%
Cash/sh 1.58 P/C 85.16 EPS next 5Y -0.47% ROE 12.80% 52W Range 120.40 - 158.34 Perf YTD -13.99%
Dividend 2.84 P/FCF 26.66 EPS past 5Y 11.00% ROI 11.70% 52W High -15.02% Beta 0.94
Dividend % 2.11% Quick Ratio 1.20 Sales past 5Y 6.00% Gross Margin 34.10% 52W Low 11.75% ATR 2.42
Employees 40000 Current Ratio 1.30 Sales Q/Q -10.70% Oper. Margin 12.70% RSI (14) 49.72 Volatility 1.73% 1.68%
Optionable Yes Debt/Eq 0.66 EPS Q/Q -39.20% Profit Margin 8.20% Rel Volume 0.62 Prev Close 135.67
Shortable Yes LT Debt/Eq 0.66 Earnings Apr 27 BMO Payout 38.40% Avg Volume 1.07M Price 134.55
Recom 2.70 SMA20 1.38% SMA50 -2.26% SMA200 -3.59% Volume 665,095 Change -0.83%
Date
Action
Analyst
Rating Change
Price Target Change
May-02-23 Downgrade BofA Securities
Buy → Neutral
$166 → $148
Apr-03-23 Upgrade Citigroup
Sell → Neutral
$125 → $142
Jan-23-23 Initiated Evercore ISI
In-line
$159
Nov-17-22 Downgrade Citigroup
Neutral → Sell
$145 → $125
Aug-22-22 Resumed Morgan Stanley
Equal-Weight
$142
Apr-04-22 Downgrade Citigroup
Buy → Neutral
$175 → $140
Feb-23-22 Downgrade UBS
Buy → Neutral
$160 → $139
Feb-02-22 Downgrade Jefferies
Buy → Hold
$135
Jan-28-22 Downgrade Deutsche Bank
Buy → Hold
$190 → $129
May-04-21 Upgrade UBS
Neutral → Buy
$135 → $158
Mar-12-21 Downgrade Robert W. Baird
Outperform → Neutral
$137
Oct-21-20 Upgrade Argus
Hold → Buy
Jul-29-20 Upgrade KeyBanc Capital Markets
Sector Weight → Overweight
$144
Jul-14-20 Upgrade BofA Securities
Neutral → Buy
$142
Jun-09-20 Upgrade Wells Fargo
Underweight → Equal Weight
$90 → $120
Jun-02-20 Upgrade Deutsche Bank
Hold → Buy
$140
Apr-28-20 Upgrade Morgan Stanley
Equal-Weight → Overweight
$139
Apr-27-20 Upgrade Wolfe Research
Underperform → Peer Perform
Apr-27-20 Upgrade Citigroup
Neutral → Buy
$113 → $130
Mar-27-20 Downgrade Morgan Stanley
Overweight → Equal-Weight
$95
Show Previous Ratings
Jun-09-23 11:45AM Jun-08-23 08:46AM Jun-07-23 01:00PM Jun-06-23 11:19AM 08:55AM
11:34AM
Loading…
Jun-05-23 11:34AM Jun-02-23 11:19AM 08:40AM Jun-01-23 01:15PM 10:00AM May-24-23 02:45PM 05:48AM May-23-23 01:15PM May-19-23 12:31PM May-18-23 11:22AM
09:55AM
Loading…
09:55AM (The Wall Street Journal)
06:57AM May-17-23 04:05PM 10:35AM May-16-23 04:15PM 01:00PM May-10-23 10:15AM May-08-23 11:35AM May-05-23 10:58AM May-04-23 07:00AM May-03-23 03:44AM May-02-23 10:10AM Apr-27-23 01:18PM 01:07PM 10:41AM
09:28AM
Loading…
09:28AM 08:05AM 06:44AM 06:34AM Apr-26-23 12:10PM Apr-20-23 09:51AM 06:57AM Apr-19-23 08:37AM Apr-18-23 09:23AM Apr-17-23 08:33AM Apr-12-23 10:55AM Apr-10-23 02:20PM 06:47AM Apr-06-23 01:30PM 09:00AM Apr-05-23 06:20AM Apr-04-23 04:00PM 11:45AM Mar-31-23 10:36AM Mar-30-23 09:00AM Mar-29-23 12:00PM 12:00PM 10:15AM Mar-28-23 11:12AM Mar-27-23 11:28AM 07:36AM Mar-23-23 11:19AM Mar-22-23 10:40AM 08:58AM Mar-21-23 10:43AM 09:05AM 09:00AM Mar-20-23 09:45AM 08:40AM Mar-16-23 06:45AM Mar-14-23 11:45AM Mar-08-23 01:35PM 01:20PM 01:00PM Mar-07-23 10:15AM Mar-03-23 04:30PM 09:44AM 09:40AM Mar-02-23 10:15AM Feb-28-23 11:40AM 09:35AM Feb-24-23 05:23AM Feb-22-23 11:50AM Feb-21-23 10:50AM Feb-16-23 01:45PM 06:45AM Feb-15-23 03:40PM 11:17AM 08:53AM Feb-14-23 06:58AM Feb-13-23 10:30AM Feb-08-23 02:40PM 07:42AM Feb-06-23 02:03AM 01:52AM Feb-05-23 07:16AM Feb-03-23 03:16PM 01:19AM Feb-02-23 02:27PM 01:58PM 11:16AM 08:05AM 07:29AM 06:45AM 06:44AM
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Doherty Catherine T. SVP, Regional Businesses Mar 07 Sale 140.55 5,307 745,899 67,810 Mar 08 04:38 PM PREVOZNIK MICHAEL E SVP & General Counsel Mar 07 Sale 140.55 4,754 668,175 38,527 Mar 08 04:39 PM Doherty Catherine T. SVP, Regional Businesses Mar 03 Sale 140.63 717 100,832 67,810 Mar 06 05:08 PM PREVOZNIK MICHAEL E SVP & General Counsel Mar 02 Sale 138.54 593 82,154 38,527 Mar 03 04:51 PM Doherty Catherine T. SVP, Regional Businesses Feb 24 Sale 141.42 1,690 239,000 68,919 Feb 27 04:42 PM PREVOZNIK MICHAEL E SVP & General Counsel Feb 24 Sale 141.42 1,415 200,109 39,440 Feb 27 04:49 PM RING TIMOTHY M Director Dec 01 Option Exercise 57.39 2,025 116,214 26,174 Dec 05 04:40 PM RING TIMOTHY M Director Dec 01 Sale 152.50 2,025 308,812 24,149 Dec 05 04:40 PM Doherty Catherine T. SVP, Regional Businesses Nov 28 Option Exercise 86.63 40,765 3,531,472 108,498 Nov 29 04:35 PM Doherty Catherine T. SVP, Regional Businesses Nov 28 Sale 149.18 40,765 6,081,262 67,733 Nov 29 04:35 PM RING TIMOTHY M Director Nov 01 Option Exercise 61.07 2,000 122,136 25,933 Nov 02 04:32 PM RING TIMOTHY M Director Nov 01 Sale 144.06 2,000 288,120 24,149 Nov 02 04:32 PM DEPPE MICHAEL J VP, Corp. Controller & CAO Oct 26 Option Exercise 53.79 15,497 833,598 47,503 Oct 27 05:35 PM DEPPE MICHAEL J VP, Corp. Controller & CAO Oct 26 Sale 145.00 15,497 2,247,065 32,013 Oct 27 05:35 PM RING TIMOTHY M Director Oct 03 Option Exercise 61.23 2,000 122,450 25,933 Oct 04 04:34 PM RING TIMOTHY M Director Oct 03 Sale 123.39 2,000 246,780 23,933 Oct 04 04:34 PM RING TIMOTHY M Director Sep 01 Option Exercise 61.23 2,000 122,450 25,933 Sep 06 07:04 PM RING TIMOTHY M Director Sep 01 Sale 125.02 2,000 250,040 23,933 Sep 06 07:04 PM RING TIMOTHY M Director Aug 01 Option Exercise 60.85 2,000 121,709 25,933 Aug 02 04:25 PM RING TIMOTHY M Director Aug 01 Sale 136.04 2,000 272,080 23,933 Aug 02 04:25 PM RING TIMOTHY M Director Jul 01 Option Exercise 57.46 2,000 114,911 25,933 Jul 05 04:35 PM RING TIMOTHY M Director Jul 01 Sale 133.47 2,000 266,940 23,933 Jul 05 04:35 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
